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This supplement is based on the proceedings of the U.S. Preventive Medicine, Inc. (USPM) Advisory Board meet-
ing, which took place on March 17, 2006 in Philadelphia, Pennsylvania. This supplement was supported by an edu-
cational grant from USPM.
A look back
Over the past few decades, the politics
of prevention have undergone an evolu-
tion. In the late 1960s and early 1970s, pre-
vention was at the forefront of healthcare
reform. With very little controversy, vac-
cination, promotion of lifestyle changes,
mass screenings, and safety regulations
became widely accepted as strategies for
improving health and reducing expendi-
tures. By the mid-1980s, some unantici-
pated outcomes of these strategies had be-
come apparent. Serious and permanent
injuries were attributed to the vaccines
used for immunizations. Lifestyle factors
EDITORIAL
DAVID B. NASH, MD, MBA
Few would dispute the premise that prevention, early detection, and early interven-
tion form the first line of defense on the disease management (DM) continuum. That be-
ing the case, our national statistics on preventive health should be raising concerns
throughout the industry. The US healthcare delivery system continues to fall woefully
short of its prevention targets. On the international scene, the United States lags behind
countries with less wealth and less technological savvy. Commentaries abound on the
problems, but recently I became aware of an organization with an exciting goal and a
novel solution for bringing preventive medicine into the mainstream.
U.S. Preventive Medicine, Inc. (USPM) was founded by Christopher Fey, a former pres-
ident and CEO of HealthCare USA, a multistate health maintenance organization, and
senior officer of Coventry Health Care Corporation. A number of years ago, Mr. Fey had
a life-altering experience. He witnessed his brother-in-law, a 39-year-old man in seem-
ingly excellent physical condition, suffer a massive stroke that resulted in permanent
right-sided paralysis, and speech and memory impairment. Following the event, physi-
cians concluded that his brother-in-law’s risk factors could have been identified and his
disease state detected by means of available technological screening devices. His was a
condition for which effective drug therapy and other interventions were available. This
event and its consequences were preventable.
Having experienced firsthand the devastating consequences of a “broken” system that
fails to respond until a condition produces symptoms, Mr. Fey became an “evangelist”
for prevention and early detection. In founding USPM, he translated an interesting con-
cept into an innovative model for preventive health in a consumer-driven market.
In the following pages we provide a brief history of and current status report on the
state of preventive health in the United States, and we present an overview of this com-
pany’s solution as one example of the untapped potential for innovation in the delivery
of preventive services. I hope that the information contained herein will inspire you and
your colleagues to join the conversation about the direction the United States will take
with regard to improving access to screening and preventive services and enriching the
lives of all citizens. As always, I welcome your comments. I can be reached at
David.Nash@jefferson.edu.
PREVENTIVE HEALTH IN THE UNITED STATES
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were being used as the basis for raising
health insurance rates and/or denying
consumer eligibility for disability bene-
fits. Preventive screenings had become
suspect as potential tools for a range of
activities, from denying employment to
selective abortion. Lawsuits were brought
charging that occupational safety stan-
dards were being used to exclude people
from certain jobs.1
In the late 1980s, the US Preventive Ser-
vices Task Force (USPSTF) launched the
first edition of its Guide to Clinical Preven-
tive Services under the auspices of the
Agency for Healthcare Research and Qual-
ity (AHRQ).2 The guide contained recom-
mendations that helped to establish the 
importance of including prevention in pri-
mary health care, ensuring health plan
coverage for effective preventive services,
and holding healthcare providers and sys-
tems accountable for delivering preventive
care. The guide has been updated period-
ically, and the guidelines contained therein
continue to form the basis of clinical stan-
dards for professional societies, healthcare
organizations, and medical quality review
groups. Current USPSTF recommenda-
tions for preventive services are listed in
Table 1.
With the growth of managed care orga-
nizations in the 1980s and 1990s, insurance
coverage for preventive services was intro-
duced, and a new emphasis was placed on
disease prevention and health education.
Primary care providers were encouraged,
and often “rewarded,” for focusing on
screening and prevention. In the early
1990s, disease state management programs
began to appear, providing aggressive pre-
vention of disease progression and com-
plications as well as treatment for chronic
conditions.
Today the United States is the world’s
richest, most technologically advanced na-
tion, but US preventive health statistics
continue to fall dramatically short of ex-
pectations. The associated costs are alarm-
ingly high. Consider the following:
• More than 20 million Americans (7% 
of the population) have diabetes,
though experts estimate that nearly
30% of this population remains undi-
agnosed.3
• According to the National Kidney Foun-
dation, more than 20 million Americans
have undetected moderate chronic kid-
ney disease and another 20 million are at
risk.4
• According to the American Heart Asso-
ciation, the lifetime risk of developing
hypertension is approximately 90% for
adults between the ages of 55 and 65; one
third of those affected are not aware they
have this condition.5
• Chronic obstructive pulmonary disease
(COPD) also warrants attention because
large numbers of cases are undiagnosed.
In 2001, at a time when more than 12 mil-
lion adults were diagnosed with COPD,
experts estimate that an additional 16
million remained undiagnosed and
therefore untreated. Failure to treat can
be fatal—COPD is the fourth leading
cause of death in the United States—and
it’s costly; in 2000, national COPD costs
totaled more than $32 billion, split nearly
evenly between direct and indirect
costs.6
• At least half of the deaths from cancers
(564,830 projected in 2006) could be pre-
vented by greater use of established
screening tests and the application of ex-
isting knowledge.7
In their recent study, “Disease and Dis-
advantage in the United States and in En-
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TABLE 1
U.S. PREVENTIVE SERVICES TASK FORCE (USPSTF) RECOMMENDED PREVENTIVE SERVICES (2005)
Adults Special populations
Pregnant
Recommendations Men Women women Children
Alcohol misuse screening and behavioral counseling interventions X X X
Aspirin for the primary prevention of cardiovascular eventsa X X
Bacteriuria, screening for asymptomatic X
Breast cancer, chemopreventionb X
Breast cancer, screeningc X
Breastfeeding, behavioral interventions to promoted X X
Cervical cancer, screeninge X
Chlamydial infection, screeningf,g X X
Colorectal cancer, screeningh X X
Dental caries in preschool children, preventioni X
Depression, screeningj X X
Diabetes mellitus in adults, screening for type 2k X X
Diet, behavioral counseling in primary care to promote a X X
healthyl
Hepatitis B virus infection, screeningm X
High blood pressure screening X X
Lipid disorders, screeningn,o X X
Obesity in adults, screeningp X X
Osteoporosis in postmenopausal women, screeningq X
Rh (D) incompatibility, screeningr,s X
Syphilis infection, screeningt X X X
Tobacco use and tobacco-caused disease, counseling to preventu,v X X X
Visual impairment in children younger than age 5 years, X
screeningw
aAdults at increased risk for coronary heart disease.
bDiscuss with women at high risk for breast cancer and at low risk for adverse effects of chemoprevention.
cMammography every 1–2 years for women 40 and older.
dStructured education and behavioral counseling programs.
eWomen who have been sexually active and have a cervix.
fSexually active women 25 and younger and other asymptomatic women at increased risk for infection.
gAsymptomatic pregnant women 25 and younger and others at increased risk.
hMen and women 50 and older.
iPrescribe oral fluoride supplementation at currently recommended doses to preschool children older than 6
months whose primary water source is deficient in fluoride.
jIn clinical practices with systems to assure accurate diagnoses, effective treatment, and follow-up.
kAdults with hypertension or hyperlipidemia.
lAdults with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease.
mPregnant women at first prenatal visit.
nMen 35 and older, and women 45 and older.
oYounger adults with other risk factors for coronary disease; screening for lipid disorders to include measure-
ment of total cholesterol and high-density lipoprotein cholesterol.
pIntensive counseling and behavioral interventions to promote sustained weight loss for obese adults.
qWomen 65 and older, and women 60 and older at increased risk for osteoporotic fractures.
rBlood typing and antibody testing at first pregnancy-related visit.
sRepeated antibody testing for unsensitized Rh (D)–negative women at 24–28 weeks gestation unless biological
father is known to be Rh (D) negative.
tPersons at increased risk and all pregnant women.
uTobacco cessation interventions for those who use tobacco.
vAugmented pregnancy-tailored counseling to pregnant women who smoke.
wTo detect amblyopia, strabismus, and defects in visual acuity.
From Guide to Clinical Preventive Services (2005). Available at: www.ahrq.gov/clinic/pocketgd/gcps1.htm.
gland,” Banks and colleagues concluded
that the US population in late middle age
is less healthy than the equivalent British
population, with respect to self-reported
chronic conditions and biological markers
of disease, despite considerably greater per
capita spending on health care (US $5274
vs. UK $2164 [adjusted].)8 The differences
reportedly exist at all levels of socioeco-
nomic status.
As a nation, our failure to detect condi-
tions and initiate early intervention has re-
sulted in a precipitous rise in the preva-
lence and severity of chronic diseases.9
Chronic conditions account for 70% of all
deaths in the United States, and the costs
associated with chronic conditions account
for more than 60% of the nation’s medical
care costs. Perhaps most unsettling is that,
for a majority of chronic diseases, onset can
be delayed or progression limited by avoid-
ing risky behaviors, increasing physical ac-
tivity, and obtaining life-saving screening
services.
Why is preventive health care so far
from where it should be in the world’s
wealthiest nation? There are a variety of
possible explanations. Some commercial
insurance carriers ration coverage by ad-
hering to conservative standards and rec-
ommendations. In the public sector, some
restrictions on coverage for preventive
services are even more stringent. For in-
stance, Medicare does not cover preven-
tive services for senior citizens, and most
Medicaid carriers restrict preventive care
to minimal standards and recommenda-
tions. But the problem is more pervasive.
A recent survey of 153,000 adults con-
cluded that only 3% of US citizens adhere
to the four key healthy lifestyle character-
istics (ie, not smoking, maintaining
healthy weight, eating adequate amounts
of fruits and vegetables, and exercising
regularly).10 Almost 10% of respondents
admitted that they did not adhere to any
of the four characteristics.
Consumer-driven healthcare and its effect on
preventive health
Several market forces are beginning to
align, creating ideal conditions for a major
transition in healthcare delivery:
1. The projected impact of the aging “baby-
boom” population
2. The ever-escalating cost of providing
health care
3. The increasing role of consumers in
managing all aspects of their health
Today more than 80 million “baby-
boomers” are beginning to attain senior sta-
tus with a previously unheard-of passion
for enjoying healthy, active lives. The im-
pact of this generation on established mar-
kets, business, and society promises to be
challenging. On the positive side, medical
and information technology are advancing
at a rapid pace, enabling ever higher de-
grees of personalized care for a population
demanding proactive care to ensure
longevity and quality of life. On the flip
side, the cost of care continues to outpace
the economy’s ability to pay for “tradi-
tional” care. In the final analysis, this pop-
ulation may leverage their considerable
wealth and political influence to make the
necessary changes in the system.
In “Wealth Patterns among Elderly
Americans: Implications for Healthcare Af-
fordability,” Knickman and colleagues
point out that, at nearly 17% of the gross
domestic product, health care is the largest
single industry in the United States.11 If this
trend continues, an aging population could
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overwhelm the economy’s ability to support
health care. The authors reason that a tradi-
tional approach (ie, “sick care”) delivers care
when treatment options are most costly and
outcomes are most limited. They observe
that business and consumer markets are be-
ginning to challenge the assumption that
medical treatment should be reserved for the
“sick.” Some examples cited are:
• Employers are beginning to understand
the value of “buying health” in reducing
absenteeism and “presenteeism.” They
are becoming interested in investing in a
healthy, productive workforce.
• Consumers want to extend their physi-
cally and mentally active years, main-
taining or improving their quality of life
as they age.
• Government must act to lower the long-
term cost of care.
Proactive preventive care is increasingly
viewed as both a logical and a necessary al-
ternative. Early diagnostic tests, assess-
ments, and aggressive intervention in ad-
vance of symptoms provide an appealing
alternative, given the lower cost of these
types of interventions and the high poten-
tial for positive outcomes at the presymp-
tomatic stage.
As consumers assume greater financial
responsibility for the cost of their personal
health care, they are likely to demand
greater influence over how their health dol-
lars are spent. Consumers may demand op-
tional tests and procedures in order to es-
tablish, in concert with their physicians, an
accurate baseline for their health. Such a
baseline can be useful when making pur-
chase decisions on the type and level of
health coverage needed. Baseline and on-
going trend information will offer con-
sumers’ clinical teams a more effective
means of monitoring their patients’ health
and changes in conditions.
The trend toward consumer-driven
health care is beginning to reset expecta-
tions regarding who pays for prevention.
Although some employers continue to pro-
vide coverage that includes preventive ser-
vices, in most cases consumers are the pur-
chasers of preventive care. The challenge
for consumers is identifying how and
where to purchase prevention.
Can prevention fit into the traditional 
care model?
One solution is for consumers to go to a
preventive care center for reliable, accurate,
and comprehensive individualized testing,
and then go to a physician for interpretation
of those test results and development of a
medical management plan. The critical fac-
tors for the success of such a solution are a
uniform, consistent, and accessible experi-
ence for the consumer and for the physician.
Market forces are already driving these
changes. A combination of factors (ie, the
financial transfer to consumers and the
trend toward proactive care) are shifting
the focus and responsibility for individual
health to the consumer. The new healthcare
consumer is assuming a larger role in his
or her personal health. For example, Heath
Savings Accounts (HSAs), in which health
spending is at the discretion of the indi-
vidual, are on the rise.
In recent years, there has been an un-
precedented rise in consumer involve-
ment in healthcare purchasing and deci-
sion making. The information necessary
for making informed healthcare decisions
is becoming readily available via the In-
ternet, personal health record (PHR) tech-
nology, public service materials, and from
healthcare insurers and employers.
CLARKE AND MEIRISS-6
Although navigating the healthcare
system in today’s environment is often
challenging and frustrating, consumers
have had no alternative but to “take
charge” in the not-so-user-friendly world
of health care. U.S. Preventive Medicine,
Inc. (USPM) sees its role as offering 
consumers the services of a “captain” to
help them plot their course for healthier,
active lives—with an emphasis on pre-
vention.
USPM was founded on the premise that
healthcare service delivery is entering a pe-
riod of transition in the United States. Tra-
ditionally, the focus of care has been reac-
tive, with services delivered only when a
patient’s illness becomes symptomatic. As
the system evolves, the focus has been
shifting increasingly to proactive, preven-
tive care in which consumers are treated on
a presymptomatic basis—a concept that
dovetails with the philosophy of disease
management.
Culture of prevention
The US healthcare system is grounded in
a medical infrastructure wherein care is
provided and reimbursed based on a per-
ceived doctor-patient relationship in which
“prevention” is defined simply: “eat right,
exercise, take vitamins, and see the doctor
regularly.” USPM’s goal is to reorganize
the prevention arena by driving a transi-
tion from “legacy of treatment” to a “cul-
ture of prevention.” Moving to a culture of
prevention entails expanding the definition
to include understanding what is going on
inside the body (eg, genetics, blood
chemistries).
Building a prevention ecosystem
The USPM model takes a comprehensive
approach to prevention, employing multi-
ple components and a multipart mission to
create a “prevention ecosystem.” The broad
goals include:
• Creating a national system of con-
sumer- and employer-focused preven-
tive care centers established in con-
junction with hospitals and physician
groups. The centers for preventive med-
icine (CPM) will provide consumers and
employers with point-of-care preventive
services for health diagnostics, assess-
ment, counseling, and medical interven-
tion as appropriate.
• Educating, informing, and motivating
consumers and employers to pursue
prevention lifestyles and to utilize vir-
tual and physical preventive services.
In a television program format with a fo-
cus on “entertainment,” the company
seeks to influence consumer health be-
haviors in areas such as fitness, healthy
aging, and wellness. Theoretically, the
convenience of receiving this informa-
tion and education in the home environ-
ment will increase the likelihood of con-
sumer involvement.
• Functioning as a holding company for
units in the “prevention ecosystem.”
Units will include a licensing group for
CPMs; The Prevention Channel; online
prevention services (ie, Preventionchan-
nel.com); group prevention services (ie,
disease management services); and re-
search (eg, data mining, clinical re-
search). USPM Holding Company rev-
enue would flow from licensing fees,
ONE COMPANY’S INNOVATIVE SOLUTION: 
THE U.S. PREVENTIVE MEDICINE, INC. MODEL
S-7
profit and revenue sharing, advertising,
products and services, “permission-
based” data mining, clinical research,
disease management, and value appre-
ciation.
USPM sees its role as a catalyst in
pulling divergent interests (ie, employers,
consumers, government) together in a
business model focused on creating a cul-
ture of prevention. Mr. Fey admits, “It
will not be a quick or cheap fix, but it
needs to happen. We need a model in
which every player wins.” An important
element in making this transition is rec-
ognizing the differences between individ-
ual consumer health and population
health; a model for individual health must
go beyond a population model approach
(eg, educating the population to exercise
and take vitamins). An individual health
model must incorporate technologies that
screen for and monitor chronic condi-
tions. “Cardiovascular disease takes 30
years to kill a person. A person with this
condition needs to know about it as early
as possible and seek appropriate treat-
ment to achieve the best outcome.”
Promoting the cause of individualized
prevention is the first step. The real
dilemma lies in moving the healthcare de-
livery system toward providing all neces-
sary preventive services. A recent article on
women’s health reported an alarmingly
high rate of missed diagnoses of heart dis-
ease in women, but there is no public out-
cry. Preventive health rarely hits the radar
screen. “People don’t walk around asking
for the nearest—or best—preventive health
center.”
The Prevention Channel. USPM’s model
envisions a communication component
with a novel intervention—a cable channel
named “The Prevention Channel.” The Pre-
vention Channel is designed to deliver pre-
vention messages in an entertaining way,
on the order of the History Channel or the
Discovery Channel. Programs or “soap op-
eras” will focus on common health ele-
ments that a viewer can change by taking
some action. For example, diabetes may be
woven into a story in such a way that view-
ers begin to understand this health issue on
a deeper, personal level. By identifying
with the characters, viewers may become
better equipped to recognize possible early
symptoms of common chronic illness in
themselves and in their family members.
Prevention topics will include heart dis-
ease, stroke, cancer screening, and aging
gracefully. The message—“70 is the new
middle age.”
PreventionChannel.com. The Prevention
Channel programs may motivate con-
sumers to take some action regarding
their personal health. Viewers with con-
cerns about their health will be directed
to virtual prevention services online (ie,
PreventionChannel.com) where they may
complete user-friendly, comprehensive
assessments that predict risk levels for
various conditions. Consumers, in collab-
oration with their healthcare providers,
can use this knowledge to determine ap-
propriate interventions and measure re-
sults.
Online and paper programs have been
designed to improve participant health and
postpone morbidity by reducing health
risks, promoting self-efficacy, and instilling
self-care skills. There are basic programs
and programs designed for the needs of
special populations. These interventions
are grounded in the science of behavioral
change and draw upon the expertise of
practicing clinicians and health educators.
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A medical director oversees panels of clin-
icians who continually review medical and
scientific literature for the most current in-
formation and incorporate it into the orga-
nization’s processes.
USPM CPMs
The core of the USPM system is a national
network of CPMs. With support from a na-
tional advisory board, a medical advisory
board, and relationships with national
medical organizations (eg, ACPM), these
centers are designed to bridge the gap be-
tween traditional, reactive medicine and
modern, proactive medicine. CPMs have
the potential for positive impact on the
quantity and quality of preventive health
in the communities they serve by “defining
the preventive experience, providing a
physical presence, and creating credibility,
content, and authority.”
In the traditional, illness-focused model,
the healthcare or hospital system is de-
signed to intervene at late, acute, or symp-
tomatic stages when outcomes are poor
and costs are high. The CPM model fo-
cuses on preventing disease from the out-
set by identifying it at the earliest point
when outcomes are best and costs are 
lowest. USPM partners with hospitals 
and physician groups in co-ownership
arrangements of its branded CPMs. Con-
ceptually, the model represents a change
in process rather than a “frontal assault.”
The company contracts with thousands of
physicians and invites the participation of
all who meet USPM’s professional and
clinical standards. The goal is for the
CPMs to become dominant regional
providers of consumer- and employer-fo-
cused prevention, wellness, and healthy
aging services.
The three components of the CPM core
structure are USPM, the hospital partner,
and the physician partners (Fig. 1). Ideally,
the CPM is located in a multispecialty
building that is near or appended to, but
not in, the hospital. Fifteen hundred square
feet is adequate space, and a CPM is de-
signed to use staff, imaging, laboratory,
and cardiology services that are already in
place at the hospital.
CPM services are rendered by physicians
in a clinical environment where assessment
and prevention protocols are tailored to in-
dividual patients rather than populations.
The challenge is to create a one-stop/one-
source for preventive care and the goal is
to establish 150 CPMs across the United
States over a five-year period that will
serve approximately 1000 patients per year
at each center. At full capacity, this repre-
sents approximately 0.1% of the US popu-
lation. The CPM does not replace the pa-
tient’s relationship with his or her doctor.
Rather, it facilitates and enhances the op-
portunity for early detection, and encour-
ages diligence among those with increased
risk factors.
The company envisions a geographical
distribution for CPMs that encompasses
both urban and rural areas. One hundred
fifty markets have been identified with pop-
ulation sizes as low as 150,000. Currently, a
CPM is operating in Sioux City, Iowa. In
terms of staffing, the hospital added only
one full-time employee, an RN administra-
tor. Patient data is stored on a secure drive.
There is a private lounge and changing
rooms, television, and computers with In-
ternet access. A concierge escorts the patient
from one diagnostic area to another. Flexi-
bility in scheduling assures little downtime
between tests. Lifestyle coaching by an RN
is included for one year following diagnos-
tic testing.
Preventive service packages are available
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BUSINESS OVERVIEW
THE CENTER FOR
PREVENTIVE MEDICINE®
OWNERSHIP:
USPM National
Medical
Advisory
Board
Medical
Director
Local Medical
Advisory
Board
Accredited Investors
Physicians
Hospital
USPM
Consumers
Employers
Flex Spending/MSAs
Some Insurers
Management Fees
Share of Profits
Management
Accredited Investors
Physicians
Turnkey System
Management Services
Marketing (Local/National)
Billing/Collections
Point of Sale/Data/Web
Physicians
Hospital
Diagnostic Imaging
Laboratory
THE CENTER FOR
PREVENTIVE
MEDICINE®
Financial Overview
Global Payment By:
U.S. PREVENTIVE
MEDICINETM
Provides:
Receives:
Corporate Ownership
Contract Services
Provided By:
Service Fees
Share of Profits
Service Fees
Share of Profits
Specialist Fees
Personal
Physician
Consult Fees
Physician Owners:
Hospital Owners:
Physician Network:
FIG. 1. U.S. Preventive Medicine, Inc. (USPM) center for preventive medicine (CPM) structure.
at different price points across the spec-
trum depending on the number and types
of screenings and/or tests performed. At
the high end, the cost per patient at a CPM
ranges from $1425 to $5950, with cardiol-
ogy-specific packages ranging from $825 to
$3415. For those desiring lower-end pre-
ventive services, employers may purchase
packages for as little as $10 per employee
per year for basic risk stratification.
In practical terms, the US healthcare sys-
tem is comprised of contracts and services.
The CPM model seeks to extend contracts
and services for preventive care beyond
their current bounds, leading to an appre-
ciable increase in wellness and continuity
of care.
National Advisory Board Reaction to the 
USPM model
With a variety of stakeholders involved
in this enterprise, it is important to recog-
nize different perspectives and address is-
sues exclusive to each stakeholder. USPM
sought the expertise of the Department of
Health Policy at Jefferson Medical College
in convening a National Advisory Board to
serve as impartial consults to the com-
pany’s strategy team (Table 2). The goal
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TABLE 2
U.S. PREVENTIVE MEDICINE, INC. (USPM) ADVISORY BOARD
F. Kenneth Ackerman, Jr., F.A.C.H.E.,
F.A.C.M.P.E.
President
Clark Counsulting Healthcare Group
Minneapolis, Minnesota
David Auerbach, M.D., M.B.A.
Associate Professor, Internal Medicine–
General Medicine
University of Texas, Southwestern 
Medical School 
Dallas, Texas
Robert N. Butler, M.D.
President and Chief Executive Officer
International Longevity Center–USA
New York, New York
Anthony DiMarino, M.D.
Division Chief
Gastroenterology and Hepatology
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
James Fries, M.D.
Professor of Medicine (Emeritus)
Stanford University
Stanford, California
Robert Goldberg, Ph.D.
Director
Center for Medical Progress
Manhattan Institute
New York, New York
Lynn Helmer, M.D., F.A.C.P., M.B.A.,
F.A.C.P.E.
President
DRD Consulting, Inc.
Haddon Heights, New Jersey
Maulik Joshi, Dr.P.H.
Former President and Chief Executive 
Officer
Delmarva Foundation for Medical 
Care, Inc.
Easton, Maryland
Matias Klein
President and Chief Technology Officer
Ethidium Health Systems
Huntingdon Valley, Pennsylvania
Ronald Loeppke, M.D., M.P.H.
Chief Medical Officer and Executive 
Vice President
CorSolutions, Inc.
Brentwood, Tennessee
S. Jay Olshansky, Ph.D.
Professor
School of Public Health
The Population Research Center at NORC
and 
The University of Chicago
Chicago, Illinois
Jason Pride, C.E.A.
Vice President and Director of Research
The Haverford Trust Company
Radnor, Pennsylvania
Ann Scott Blouin, Ph.D., R.N.
Principal
Deloitte Consulting LLP
Chicago, Illinois
Richard Tewksbury
Manager Business Development
TRION Group
King of Prussia, Pennsylvania
was to obtain objective feedback on the 
company’s broad “ecosystem” approach to
transforming preventive health care, and to
elicit critique regarding the CPMs from clin-
ical, financial, and business perspectives.
The National Advisory Board, comprised
of national-caliber healthcare industry lead-
ers (up to 12 members representing medical
specialties, healthcare administration, and
employers), met in Philadelphia, Pennsylva-
nia on March 17, 2006. At its initial meeting,
the board reviewed USPM concepts and the
existing business model, identified potential
risks and barriers, discussed the application
of evidence-based practices, and outlined an
outcomes research strategy. The board is ex-
pected to reconvene periodically to provide
guidance during the development of the
CPMs.
The chief questions posed were: Can this
model work? Does it make economic and
clinical sense? Board members agreed that
the USPM model represents a very innova-
tive view of preventive medicine. They
noted that the concepts represent a depar-
ture from the conventional “public health”
approach to prevention, focusing instead on
privatization of the preventive health model.
One member observed, “The model is an in-
teresting interface between high-tech and
high-touch.”
The USPM National Advisory Board
noted that the CPM product is highly indi-
vidualized for the client/consumer but
must be rigorously standardized across
centers and regions (eg, a test for detecting
melanoma cannot be available at one cen-
ter and not another). If the screening tool
(eg, a health status and risk assessment)
recommends a screening test or study to
consumers, it must be integrated into the
preventive options offered.
The opportunity exists to redefine US pre-
ventive medicine in terms of what it can be.
The World Health Organization defines
health in broad terms, balancing physical,
emotional, social, and spiritual elements. The
Board suggested that a comprehensive defi-
nition of preventive medicine be built
around this model. Such a definition would
span the continuum from primary preven-
tion to early intervention to tertiary preven-
tion (ie, treating to prevent complications).
The Board encouraged the company to
continue to focus on helping individuals to
manage their own health and to negotiate the
healthcare process. Several members ad-
vised that the preventive medicine program
include such things as advance directives
and end-of-life care in addition to the risk as-
sessments and screening tests. They ques-
tioned “What is done with a positive find-
ing?” and, “Where will consumers be told to
‘start taking a baby aspirin’?” With this
model, these fall into the healthcare
provider’s domain. “We want an organiza-
tion that is both accessible and economical—
one that avoids duplicating effort.” The com-
pany is working on standardizing the
information reported on each test per-
formed, and the company’s Web site will
provide additional detail for physicians and
for individuals who have concerns.
Employer-related issues. The chief issue for
employers is the differential in the value
propositions. “Productivity is the new cur-
rency for employers looking to ‘buy health’
for their workforces.” Employers are seek-
ing products that cover all health care for
all of their employees—both prevention
and treatment. The concierge-style CPMs
are impressive, but they are designed and
priced for executives. Board members en-
couraged the company to focus similar 
attention on continued development of
products and services employers might
purchase for their general workforces.
CLARKE AND MEIRISS-12
Physician-related issues. Several Board
members noted potential challenges at the
provider level in the model. “What are the
implications if a patient is diagnosed with
a genetic disorder or predisposition?” The
Board also commented on the potential for
resistance from physicians when subclini-
cal or presumptive diagnostics are intro-
duced. “Physicians resist having their pa-
tients get tests outside of the doctor-patient
context.”
The Board discussed the importance of ed-
ucating physicians regarding the signifi-
cance of specific tests and counseling scores.
The key message was that maintaining good
relationships with physicians will be critical
to the success of the model. “Always ask the
name of the person’s doctor and report to
that doctor before the patient does.”
Ethical issues. As they are presently 
conceived, CPMs are accessible to and af-
fordable by “high-end” consumers (ie, em-
ployer-sponsored executives and con-
sumers willing and able to pay $1500 out
of pocket). Although other components are
more universally accessible (eg, The Pre-
vention Channel), the Board cautioned that
the CPMs may give the appearance of elit-
ism or “cherry picking.” They encouraged
the company to focus some of its innova-
tive capital on a solution to address pre-
vention for the huge uninsured US popu-
lation, as well as those insured by Medicare
and Medicaid. Additional opportunities in-
clude fashioning programs for specific em-
ployers (eg, police, firefighters) and pro-
grams that consider regional culture,
making certain that customer service train-
ing extends to the physician.
While sensitive to this critique, USPM re-
ported that experience at its prototype
CPM in Sioux City, Iowa suggests that ed-
ucated consumers are interested in invest-
ing in personal prevention and early de-
tection. Also, plans are under way to pro-
vide affordable screening programs via a
Web-based health status and risk assess-
ment tool, and education via “The Preven-
tion Channel.”
Partnering. The Board advised USPM to
choose its hospital and physician partners
very carefully to ensure the best clinical
quality in a given region. “Selection of part-
ners will set the tone relative to perceived
quality.”
Business model. The model assumes un-
used capacity at hospitals. For example, the
hospital with the fully operational CPM has
an entire wing dedicated to prevention and
fitness. Board members commented that
many hospitals in the United States and
Canada have no excess capacity.
Medical content and standards
The Board emphasized the importance of
establishing and maintaining standards of
care and evaluating quality across CPMs.
They raised questions about the practice of
individual medicine as contrasted with
population medicine. Even though most
people are risk averse there are exceptions,
and the permissible degree of variation
from the standard must be established (eg,
a consumer who desires a liver biopsy
every three months when the risk of dying
from the test is greater than the risk of dy-
ing from the disease).
The Board stressed the value of involv-
ing clinical partners in clinical content de-
terminations and package designs. There
should be a valid reason for doing each
test—one that is understood by the con-
sumer and the physician. Additional de-
mands on physician time may be alleviated
in part by developing decision trees.
PREVENTIVE MEDICINE: A “CURE” FOR THE HEALTHCARE CRISIS S-13
Additional “prevention package” offer-
ings suggested by the Board were a cardi-
ology service package, and a women’s pre-
ventive health package (ie, reproductive
health, cardiovascular, osteoporosis
screening).
Evidence-based medicine. The healthcare in-
dustry is seeking evidence-based medicine.
Purchasers, providers, and consumers ex-
pect it. Wherever possible, there should be
evidence to support the program. Increas-
ingly, the onus of responsibility for an indi-
vidual’s health is on the consumer. Because
of this, it is important to educate and help
manage the expectations of consumers.
The Board noted that the model deals as
much with “early discovery” as with pre-
vention. In deciding whether to be totally
evidence based (ie, adhere to relatively con-
servative USPSTF recommendations) or to
follow suggestions from the most current
literature (ie, practice cutting-edge preven-
tion and early detection), the Board advised
taking a proactive approach. “Framingham
cannot predict for individuals. It is only
useful for populations.”
Outcomes measures and studies. Outcomes
measurements are essential for demonstrat-
ing the positive effects of the model—for ex-
ample, a reduction in morbidity or mortality
that results in increased productivity. The
Board strongly recommended that USPM
create a research arm to track participants in
programs and analyze data for changes in
behavior and health risks. They noted rich
sources of data including existing data from
CPMs, online health status surveys, and risk
assessments. In addition to studies, the
Board stressed the importance of conducting
scholarly reviews of the literature.
Observational studies might be designed
to evaluate the effect of USPM’s programs
and answer important questions such as:
• If the expected outcome is extended
“healthy life,” gauge and monitor this.
• Does participation reduce the risk of
death?
• Does participation increase the quality of
life?
• Does living a healthier life lead to greater
accumulation of wealth?
• Does living a healthier life result in fewer
sick days and more productivity at work?
• What is an acceptable outcome? Does
early detection always result in a better
outcome?
Preventive care is a long-term commit-
ment. One would expect differences in costs
for a person aged 50 versus a person aged 60.
A study comparing out-of-pocket and other
costs for participants versus nonparticipants
at various ages would be of great interest.
An information technology system is an
integral part of a research solution. Health
status assessments, procedures, and test re-
sults form a core data set and an umbrella
questionnaire could be administered annu-
ally to all program participants with eval-
uation embedded into the system. Another
element to consider is a PHR on the Web
site that would enable integration of the in-
dividual participant’s prevention experi-
ence and test results.
By the meeting’s end, the key points were
synthesized in the form of a proposed mis-
sion statement:
1. Improve American health.
2. Improve individual health via lifestyle
changes.
3. Detect disease at an early stage.
4. Evaluate outcomes of prevention efforts
thoroughly.
5. Conduct scholarly reviews of the litera-
ture.
6. Ensure adequate financial return for
preventive services.
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CONCLUSION
The US healthcare system’s failure to
meet targets for prevention and early de-
tection of chronic conditions has raised
concerns throughout the industry. Al-
though improvements have resulted from
the efforts of health plans, disease man-
agement companies, and public sector
agencies, preventive health care continues
to fall short of expectations for a variety
of reasons including system issues (eg, ra-
tioning or restricting coverage for preven-
tive services by insurers) and consumer
behavior issues (eg, failure to adhere to
key healthy lifestyle characteristics). In
this supplement, we have described one
innovative strategy for improving the
amount and quality of prevention, early
detection, and healthy lifestyle educa-
tion—the creation of a national network of
CPMs delivering consistent, reliable pre-
ventive services and solutions to con-
sumers across the country. We also pres-
ent a national expert panel’s reaction to
the strategy. The USPM model is of par-
ticular interest because of its broad, en-
compassing scope—the “ecosystem” con-
cept—and its novel approaches to
physician and hospital partnering, diag-
nostic/screening test packaging and de-
livery, and consumer engagement and ed-
ucation regarding preventive health.
In the months since the National Advi-
sory Board met to evaluate and critique its
model, USPM executives have worked to
address the board’s recommendations (eg,
seeking, as partners, institutions with a
“passion for prevention,” taking steps to-
ward building a research arm).
Although we have highlighted one ap-
proach in this supplement, there are other
possible routes to improving preventive
health nationwide. The overarching mes-
sage is that refocusing on prevention and
early detection may be the first stage in a
“cure” for the healthcare crisis in the
United States.
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